Patient fibroblast cells showed reduced serine and glycine biosynthesis, rescuable by pyruvate supplementation.<h4>Conclusion</h4>These findings expand the phenotypic spectrum of GOT2 deficiency, establish it as a cause of developmental epileptic encephalopathy, and propose novel biomarkers for diagnosis and treatment. This evidence concerns the gene GOT2 and developmental and epileptic encephalopathy.